Abstract
The morphological and functional alterations of the smooth endoplasmic reticulum of the liver cell related to biliary stasis have brought attention to drug biotransformation during cholestasis. The metabolism of meprobamate, pentobarbital and tolbutamide was assessed in subjects with intrahepatic recurrent cholestasis (3), cholestatic hepatitis (6), extrahepatic biliary obstruction (7) and normal controls (16). In the patients with recurrent intrahepatic cholestasis no differences in drug metabolism were noted as compared to the control group. In cholestatic hepatitis the plasma half-lives of meprobamate (828 +/- 422 min.) and pentobarbital (39+-65) were significantly longer than in in controls (444 +/- 37 and 25.4 +/- 1.1 respectively). Tolbutamide plasma half-life appeared unchanged. The most striking variations were observed in the patients with extrahepatic biliary obstruction. In such cases while meprobamate half-life was unchanged, pentobarbital half-life was significantly prolonged (31.2 +/- 2.5) and the in vitro metabolism of the drug, using liver preparations, was decreased to less than 50% of the control value. In contrast the metabolism of tolbutamide was accelerated as evidenced by a significant decrease of plasma h...Continue Reading
References
Mar 1, 1972·European Journal of Clinical Pharmacology·B SchoeneH F von Oldershausen
Aug 16, 1969·Lancet·F Schaffner, H Popper
Feb 1, 1970·Proceedings of the Society for Experimental Biology and Medicine·F HuttererH Popper
Aug 8, 1970·Life Sciences. Pt. 2: Biochemistry, General and Molecular Biology·F HuttererH Popper
Feb 1, 1972·Biochemical Pharmacology·F J DarbyD A Evans
Sep 1, 1971·European Journal of Clinical Investigation·N CarulliG F Salvioli
Sep 1, 1971·British Journal of Pharmacology·C D Klaassen
Jan 15, 1969·Klinische Wochenschrift·H Held, H F von Oldershausen
May 1, 1970·Klinische Wochenschrift·H F von OldershausenH Remmer
Apr 1, 1971·Experimental and Molecular Pathology·H DenkH Popper
Jul 1, 1966·Journal of Medicinal Chemistry·R C Thomas, G J Ikeda
May 15, 1957·Klinische Wochenschrift·H SPINGLER
Sep 1, 1963·Diabetes·H UEDAH MAEZAWA
Dec 1, 1964·The American Journal of the Medical Sciences·E NELSON
Citations
Jan 1, 1990·European Journal of Clinical Pharmacology·J CottingJ Reichen
Jan 1, 1984·European Journal of Clinical Pharmacology·U Breyer-PfaffE H Egberts
Aug 1, 1981·Digestive Diseases and Sciences·J P MiguetP Carayon
Apr 1, 1995·European Journal of Drug Metabolism and Pharmacokinetics·J WójcickiU Gołdyn
Jan 1, 1996·British Journal of Pharmacology·J WójcickiL Rózewicka
Dec 24, 1997·The Journal of Pharmacy and Pharmacology·M WójcickiJ Zakrzewski
Oct 24, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·M WójcickiL Rózewicka
Oct 21, 2009·Chemistry & Biodiversity·Stefanie D Krämer, Bernard Testa